Benzenesulfonamides
Medchemexpress LLC HY-103000 2mg Medchemexpress, HSF1A CAS:1196723-93-9 Purity:>98%
Medchemexpress, HY-103000 2mg HSF1A CAS:1196723-93-9 HSF1A is a cell-permeable activator of heat shock transcription factor 1 (HSF1). Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC IACS-13909 | 2160546-07-4 | 99.97% | 377.27 | 25 MG
IACS-13909 is a selective, potent, and orally active SHP2 allosteric inhibitor with an IC50 of 15.7 nM and a Kd of 32 nM. It demonstrates greater selectivity for SHP2 compared to other phosphatases, including SHP1. This compound exhibits antitumor activities and effectively suppresses MAPK pathway signaling in receptor tyrosine kinase (RTK)-dependent cancers.
- Selective, potent, and orally active SHP2 allosteric inhibitor
- Greater selectivity for SHP2 compared to other phosphatases
- Exhibits antitumor activities
- Suppresses MAPK pathway signaling in RTK-dependent cancers
Medchemexpress LLC ALK kinase inhibitor-1 | 1462949-64-9 | 99.87% | 537.65 | 50 MG
ALK kinase inhibitor-1 is an anaplastic lymphoma kinase (ALK) inhibitor extracted from patent US20130261106A1 compound I-202. It is for research use only and not sold to patients.
- An anaplastic lymphoma kinase (ALK) inhibitor
Medchemexpress LLC HY-50907 200mg , ABT-737 CAS:852808-04-9 Purity:98%
Medchemexpress, HY-50907 200mg ABT-737 CAS:852808-04-9 Formula:C42H45ClN6O5S2 EC50: 78.7 nM (Bcl-xL), 30.3 nM (Bcl-2), 197.8 nM (Bcl-w) Purity:98% ABT-737 is a BH3 mimetic inhibitor of Bcl-xL , Bcl-2 and Bcl-w with EC 50 of 78.7 nM, 30.3 nM and 197.8 nM in cell-free assays, respectively, and shows no inhibition against Mcl-1, Bcl-B or Bfl-1. Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
eMolecules 2831-66-5 | 2,4-dichloro-1,3,5-triazine | Pharmablock | MFCD04115347 | 149.960 | C3HCl2N3 | 97.000 | Clc1ncnc(Cl)n1 | 250mg | 551204044
2,4-dichloro-1,3,5-triazine | Pharmablock | 2831-66-5 | MFCD04115347 | 149.960 | C3HCl2N3 | 97.000 | Clc1ncnc(Cl)n1 | 250mg | 551204044
Medchemexpress LLC HY-15531 50mg Medchemexpress, Venetoclax CAS:1257044-40-8 Purity:>98%
Medchemexpress, HY-15531 50mg Venetoclax CAS:1257044-40-8 Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0.01 nM. Venetoclax induces autophagy[2][3]. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC HY-15025A 50mg Medchemexpress, Sildenafil (citrate) CAS:171599-83-0 Purity:>98%
Medchemexpress, HY-15025A 50mg Sildenafil (citrate) CAS:171599-83-0 Sildenafil citrate is a potent phosphodiesterase type 5 (PDE5) inhibitor with IC50 of 5.22 nM. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Accela Chembio Inc N-cyclopropyl 4-nitrophenylsulfonamide | 5g | 549476-61-1 | MFCD00458256 | 97+% | Shelf Life: 2520 Days | Regular
N-cyclopropyl 4-nitrophenylsulfonamide | 5g | 549476-61-1 | MFCD00458256 | 97+% | Shelf Life: 2520 Days | Regular
Medchemexpress LLC Orexin receptor antagonist 3 | 1293282-55-9 | 99.6% | C21H22N8O3 | 10MG
Orexin receptor antagonist 3 is a research-grade small-molecule antagonist of orexin receptors (example 216 from patent WO2011050198A1) provided for preclinical pharmacology and formulation studies. It is identified by CAS 1293282-55-9, has molecular formula C21H22N8O3 and a molecular weight of 434.45 g/mol.
Medchemexpress LLC Orexin receptor antagonist 2 | 1457940-75-8 | 98.1% | C25H31N5O2 | 10MG
Orexin receptor antagonist 2 is a small-molecule research compound described as a potent antagonist of orexin receptors, with reported pKi values of 7.69 and 9.78. It is provided in high purity and in both solid and solution formats for preclinical and in vitro studies related to sleep regulation and insomnia research. Handle as a laboratory reagent; not for human or veterinary use.
- High purity (98.08%) suitable for research
- Reported pKi values of 7.69 and 9.78 for orexin receptor activity
- Available as powder and as a DMSO solution for convenient dosing
- Storage recommendations support extended shelf life under proper conditions
- Suitable for in vitro pharmacology and preclinical sleep research
Accela Chembio Inc N-tert-butyl 4-nitrophenylsulfonamide | 5g | 49690-09-7 | MFCD00443679 | 97+% | Shelf Life: 2520 Days | Regular
N-tert-butyl 4-nitrophenylsulfonamide | 5g | 49690-09-7 | MFCD00443679 | 97+% | Shelf Life: 2520 Days | Regular
Accela Chembio Inc N-tert-butyl 4-nitrophenylsulfonamide | 25g | 49690-09-7 | MFCD00443679 | 97+% | Shelf Life: 2520 Days | Regular
N-tert-butyl 4-nitrophenylsulfonamide | 25g | 49690-09-7 | MFCD00443679 | 97+% | Shelf Life: 2520 Days | Regular